Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Pressure BioSciences Inc. (PBIO : OTC)
 
 • Company Description   
Pressure BioSciences, Inc is a company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (35,000 psi and greater) to control bio- molecular interactions. Pressure BioSciences holds US and foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification.

Number of Employees: 12

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.70 Daily Weekly Monthly
20 Day Moving Average: 17,813 shares
Shares Outstanding: 8.79 (millions)
Market Capitalization: $14.94 (millions)
Beta: 0.70
52 Week High: $4.98
52 Week Low: $1.58
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.49% 4.23%
12 Week -19.05% -14.77%
Year To Date -26.41% -14.22%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
14 NORFOLK AVENUE
-
SOUTH EASTON,MA 02375
USA
ph: 508-230-1828
fax: 508-230-1829
ir@pressurebiosciences.com http://www.pressurebiosciences.com
 
 • General Corporate Information   
Officers
Richard T. Schumacher - Chief Executive Officer; President; CFO and Direct
Jeffrey N. Peterson - Chairman
Mickey Urdea - Director
Vito J. Mangiardi - Director
Kevin A. Pollack - Director

Peer Information
Pressure BioSciences Inc. (ABMD)
Pressure BioSciences Inc. (DMDS)
Pressure BioSciences Inc. (CPWY.)
Pressure BioSciences Inc. (EQUR)
Pressure BioSciences Inc. (ECIA)
Pressure BioSciences Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 74112E208
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 05/18/22
Share - Related Items
Shares Outstanding: 8.79
Most Recent Split Date: 6.00 (0.03:1)
Beta: 0.70
Market Capitalization: $14.94 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/18/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 7.46
EPS Growth
vs. Year Ago Period: 63.64%
vs. Previous Quarter: 51.22%
Sales Growth
vs. Year Ago Period: 90.91%
vs. Previous Quarter: -39.19%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -735.75
09/30/21 - -785.50
Current Ratio
03/31/22 - -
12/31/21 - 0.08
09/30/21 - 0.12
Quick Ratio
03/31/22 - -
12/31/21 - 0.03
09/30/21 - 0.08
Operating Margin
03/31/22 - -
12/31/21 - -1,006.69
09/30/21 - -1,105.72
Net Margin
03/31/22 - -
12/31/21 - -1,006.69
09/30/21 - -1,105.72
Pre-Tax Margin
03/31/22 - -
12/31/21 - -1,006.64
09/30/21 - -1,105.72
Book Value
03/31/22 - -
12/31/21 - -2.63
09/30/21 - -2.74
Inventory Turnover
03/31/22 - -
12/31/21 - 1.26
09/30/21 - 1.31
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©